Moriguchi Michihisa | Division Of Diagnostic Radiology Shizuoka Cancer Center Hospital
スポンサーリンク
概要
- MORIGUCHI Michihisaの詳細を見る
- 同名の論文著者
- Division Of Diagnostic Radiology Shizuoka Cancer Center Hospitalの論文著者
関連著者
-
Moriguchi Michihisa
Division Of Diagnostic Radiology Shizuoka Cancer Center Hospital
-
Asakura Kouiku
Division Of Diagnostic Radiology Shizuoka Cancer Center Hospital
-
KANEMOTO HIDEYUKI
Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital
-
Uesaka Katsuhiko
Division Of Hepato-biliary-pancreatic Surgery Shizuoka Cancer Center Hospital
-
Kanemoto Hideyuki
Division Of Hepato-biliary-pancreatic Surgery Shizuoka Cancer Center Hospital
-
Sasaki Keiko
Division Of Diagnostic Pathology Shizuoka Cancer Center Hospital
-
Endo Masahiro
Division Of Accelerator Physics And Engineering National Institute Of Radiological Sciences
-
Mizuno Takashi
Division Of Applied Life Sciences Graduate School Of Agriculture Kyoto University
-
Sugiura Teiichi
Division Of Surgical Oncology Department Of Surgery Nagoya University Graduate School Of Medicine
-
SUMIYOSHI Tatsuaki
Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital
-
ASAKURA Kouiku
Division of Diagnostic Radiology, Shizuoka Cancer Center Hospital
-
Sumiyoshi Tatsuaki
Division Of Hepato-biliary-pancreatic Surgery Shizuoka Cancer Center Hospital
-
Mizuno Takashi
Division Of Hepato-biliary-pancreatic Surgery Shizuoka Cancer Center Hospital
-
Sugiura Teiichi
Division Of Hepato-biliary-pancreatic Surgery Shizuoka Cancer Center Hospital
-
SAWADA Akihiro
Division of Diagnostic Radiology, Shizuoka Cancer Center
-
KANEMOTO Hideyuki
Division of Hepato-Biliary-Pancreatic Surger, Shizuoka Cancer Center
-
ARAMAKI Takeshi
Division of Diagnostic Radiology, Shizuoka Cancer Center
-
BEKKU Emima
Division of Diagnostic Radiology, Shizuoka Cancer Center
著作論文
- Liver-specific contrast agent-enhanced magnetic resonance and ^F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma : report of a case
- Comparison of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinoma